Aprea Therapeutics, Inc. (APRE) Stock
APRE Key Statistics
About Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
CEO: Oren Gilad. Company website
APRE — Frequently Asked Questions
What is the APRE stock price today?
Aprea Therapeutics, Inc. (APRE) trades at $0.81, up 25.75% on the day, as of Sep 20, 2026 14:59 UTC.
What is Aprea Therapeutics, Inc.'s market cap?
Aprea Therapeutics, Inc. has a market capitalisation of $5.23M, calculated from the live APRE share price and shares outstanding.
What is the P/E ratio of APRE?
APRE has no meaningful price-to-earnings ratio: Aprea Therapeutics, Inc. lost $1.98 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Aprea Therapeutics, Inc. make?
Aprea Therapeutics, Inc. generated revenue of $285,759.00 over the trailing twelve months, which puts the stock at 18.30 times sales.
What is the 52-week range for APRE?
APRE has traded between $0.59 and $0.96 over the past 52 weeks, and the last price is 15.9% below that high.
Is Aprea Therapeutics, Inc. profitable?
No. Aprea Therapeutics, Inc. is loss-making, with a net margin of -4,409.16% over the trailing twelve months.
What is the analyst price target for APRE?
Wall Street analysts rate APRE Buy.
What sector is Aprea Therapeutics, Inc. in?
Aprea Therapeutics, Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .
Who is the CEO of Aprea Therapeutics, Inc.?
Oren Gilad is the chief executive of Aprea Therapeutics, Inc., which employs 8 people.
Where can I track APRE in real time?
QFI Terminal shows APRE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See APRE live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open APRE in Terminal See plans